Integrity – Biomarkers

Reliable biomarker data in context, at a glance

Minimize risk by making better, more informed biomarker decisions.

Integrity – Biomarkers is the first database to standardize terminology and classify biomarkers reliably into lifecycle phases and disciplines. As an add-on to Integrity, Integrity – Biomarkers helps improve cost efficiency, predict and minimize risk and avoid late stage attrition.

Integrity – Biomarkers provides a wealth of reliable, high-quality, continually updated information supporting biomarker research at every stage of the drug R&D process.

Integrity – Biomarkers can help you to:

  • Understand the biology of the disease you’re working on, as well as the research status for biomarkers in your therapy area.
  • Choose the biomarker that will provide early indications of the impact of target modification on the disease process.
  • Find the biomarkers that show the effects of your compound on the disease state.
  • Select suitable biomarkers for use in safety and efficacy studies to give early indication of toxicity and proof of concept.
  • Substantiate claims and develop clinical guidelines by consulting a body of carefully curated biomarker information.
  • Determine the population that will respond best to the particular treatment.
  • Identify biomarkers to advance the design and efficacy of your studies and improve your probability of success.
  • Connect experimental research and clinical studies for pivotal insights.
  • Assign the right biomarker to the right project as early as possible.
  • Evaluate evidence (both supporting and refuting) to assess the relative merits of a biomarker for your own research.

For more information about Integrity – Biomarkers please download our product fact sheet

Speak to our team

Want to learn more about Integrity – Biomarkers?

Contact us